13F

Stock

Ascendis Pharma A/S

ASND · held by 15 managers

Reported value

$136.3M

Holders

15

+1 new · −0 exited

Holders’ est. mark

$284.3K

Price effect on 3 books still in the name

Largest holder

$86.2M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY4.36M$86.2MHeld
BANK OF AMERICA CORP /DE/678K$30.1MHeld
Hudson Bay Capital Management LP78.9K$15.7MHeld
BARCLAYS PLC10.8K$2.14M$282.6KAdded$84.6K
Persistent Asset Partners Ltd6.33K$1.26MHeld
GROUPAMA ASSET MANAGMENT400K$534.7KHeld
FARALLON CAPITAL MANAGEMENT LLC1.4K$278.3KNew
Aventura Private Wealth, LLC57$11.3K$1.49KAdded$1.49K
Allworth Financial LP14$2.78KHeld
Leonteq Securities AG8$1.59K$209Added$209
IFP Advisors, Inc6$1.19KHeld
Kilter Group LLC1$199Held
KBC Group NV356$71Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.